Matthew Lawlor to Drug Monitoring
This is a "connection" page, showing publications Matthew Lawlor has written about Drug Monitoring.
Connection Strength
0.169
-
Lawlor M, Gupta A, Ranard LS, Madhavan MV, Li J, Eisenberger A, Parikh SA, Sethi SS, Masoumi A. Discordance in activated partial thromboplastin time and anti-factor Xa levels in COVID-19 patients on heparin therapy. Thromb Res. 2021 02; 198:79-82.
Score: 0.169